Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 32, Issue 1, Pages 173-188Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-011-9599-2
Keywords
Activated CD44; FoxP3; hematological diseases; regulatory T cells
Categories
Funding
- Fresenius Biotech GmbH, Munich, Germany
Ask authors/readers for more resources
We show here that the anti-T lymphocyte immunoglobulin (ATG) can induce Treg cells following 24-h incubation in human peripheral blood mononuclear cells (PBMCs). The ATG-induced Treg cells express known cell surface markers (e. g., CD25, FoxP3) and suppress the proliferation of autologous responder PBMCs, stimulated with allogeneic PBMCs, when added into the mixed lymphocyte culture (MLC) at zero time point or 48 h later. We expanded the characteristics of the ATG-induced human Treg cells by showing that they express a novel biomarker designated activated CD44. ATG-induced Treg cells retain their suppressor function after freezing and thawing or irradiation. Suppression of MLC by ATG-induced Treg cells is consistently seen when the Treg cells and the responder cells were derived from the same donor, but not when they derived from different donors. Finally, patients undergoing stem cell transplantation and conditioned with ATG generate in vivo Treg cells that suppress MLC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available